Literature DB >> 18627513

Successful unrelated cord blood transplantation for chronic granulomatous disease: a case report and review of the literature.

Kazuhiro Mochizuki1, Atsushi Kikuta, Masaki Ito, Mitsuko Akaihata, Hideki Sano, Hitoshi Ohto, Mitsuaki Hosoya.   

Abstract

CGD is a rare inherited immunodeficiency disorder that is caused by disability of oxidative killing. We presented a two-yr-old boy with CGD who was suffering from multiple systemic abscesses. He received the first BMT from his HLA-haploidentical mother after conditioning with Flu, melphalan, and ATG. Although the maximum of 42% donor chimerism was achieved, it disappeared 73 days after the BMT. Then, we performed 5/6-matched unrelated cord blood re-transplantation after conditioning with Flu, Bu, and TBI (2 Gy). Engraftment and complete donor chimerism were achieved on days 18 and 19, respectively. The patient is now free from infection and maintains complete donor chimerism without GVHD 36 months after the cord blood re-transplantation. We postulate that the unrelated CBT has a potential to be an alternative strategy and might be beneficial for patients with CGD who do not have an HLA-identical donor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627513     DOI: 10.1111/j.1399-3046.2008.00996.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  6 in total

Review 1.  Chronic granulomatous disease: overview and hematopoietic stem cell transplantation.

Authors:  Elizabeth M Kang; Betty E Marciano; SukSee DeRavin; Kol A Zarember; Steven M Holland; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

2.  Successful unrelated donor cord blood transplantation for chronic granulomatous disease.

Authors:  Tang-Her Jaing; Wen I Lee; Po-Jen Cheng; Shih-Hsiang Chen; Jing-Long Huang; Yung-Kuei Soong
Journal:  Int J Hematol       Date:  2010-03-12       Impact factor: 2.490

3.  A Cohort of 169 Chronic Granulomatous Disease Patients Exposed to BCG Vaccination: a Retrospective Study from a Single Center in Shanghai, China (2004-2017).

Authors:  Qinhua Zhou; Xiaoying Hui; Wenjing Ying; Jia Hou; Wenjie Wang; Danru Liu; Ying Wang; Yeheng Yu; Jingyi Wang; Jinqiao Sun; Qian Zhang; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2018-03-20       Impact factor: 8.317

4.  Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.

Authors:  Priti Tewari; Paul L Martin; Adam Mendizabal; Suhag H Parikh; Kristin M Page; Timothy A Driscoll; Harry L Malech; Joanne Kurtzberg; Vinod K Prasad
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-10       Impact factor: 5.742

5.  Chronic Granulomatous Disease: A Large, Single-center US Experience.

Authors:  Pietro Bortoletto; Kyle Lyman; Andres Camacho; Marielle Fricchione; Aaruni Khanolkar; Ben Z Katz
Journal:  Pediatr Infect Dis J       Date:  2015-10       Impact factor: 2.129

Review 6.  Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.

Authors:  James A Connelly; Rebecca Marsh; Suhag Parikh; Julie-An Talano
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.